Pseudomonas aeruginosa alginate overproduction promotes coexistence with Staphylococcus aureus in a model of cystic fibrosis respiratory infection

mBio

Volumn 8, Issue 2, 2017, Pages

  Limoli, Dominique H ^a,b   Whitfield, Gregory B ^c   Kitao, Tomoe ^d,e,f   Ivey, Melissa L ^b,h   Davis, Michael R ^g,i   Grahl, Nora ^a   Hogan, Deborah A ^a   Rahme, Laurence G ^d,e,f   Howell, P Lynne ^c   O’Toole, George A ^a   Goldberg, Joanna B ^b,g  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f SHRINERS HOSPITALS FOR CHILDREN   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ SWEET BRIAR COLLEGE   (United States)

Author keywords

Biofilm; Cystic fibrosis; Mucoid; Polymicrobial; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

2 HEPTYL 4 HYDROXYQUINOLINE 1 OXIDE; ALGINIC ACID; PYOVERDINE; RHAMNOLIPID; SIDEROPHORE; SIGMA FACTOR; GLUCURONIC ACID; HEXURONIC ACID;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; COCULTURE; COMPETITIVE ABILITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE EXPRESSION; HUMAN; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGULON; RESPIRATORY TRACT INFECTION; SPECIES COEXISTENCE; STAPHYLOCOCCUS AUREUS; COMPLICATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; MIXED INFECTION; ORGANISMAL INTERACTION; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS INFECTION; THEORETICAL MODEL;

ALGINATES; COINFECTION; CYSTIC FIBROSIS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MICROBIAL INTERACTIONS; MODELS, THEORETICAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85019052752     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00186-17     Document Type: Article

References (67)

1. Taylor-Robinson D, Whitehead M, Diderichsen F, Olesen HV, Pressler T, Smyth RL, Diggle P. 2012. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 67:860-866. https://doi.org/10.1136/thoraxjnl-2011-200953.
2. Filkins LM, O’Toole GA. 2015. Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLo S Pathog 11:e1005258. https://doi.org/10.1371/journal.ppat.1005258.
3. Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22:582-610. https://doi.org/10.1128/CMR.00040-09.
4. Mc Callum N, Berger-Bachi B, Senn MM. 2010. Regulation of antibiotic resistance in Staphylococcus aureus. Int J Med Microbiol 300:118-129. https://doi.org/10.1016/j.ijmm.2009.08.015.
5. Talwalkar JS, Murray TS. 2016. The approach to Pseudomonas aeruginosa in cystic fibrosis. Clin Chest Med 37:69-81. https://doi.org/10.1016/j.ccm.2015.10.004.
6. Nguyen AT, Oglesby-Sherrouse AG. 2016. Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections. Appl Microbiol Biotechnol 100:6141-6148. https://doi.org/10.1007/s00253-016-7596-3.
7. Machan ZA, Taylor GW, Pitt TL, Cole PJ, Wilson R. 1992. 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother 30:615-623. https:// doi.org/10.1093/jac/30.5.615.
8. Mashburn LM, Jett AM, Akins DR, Whiteley M. 2005. Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J Bacteriol 187:554-566. https://doi.org/10.1128/JB.187.2.554-566.2005.
9. Hoffman LR, Deziel E, D’Argenio DA, Lepine F, Emerson J, Mc Namara S, Gibson RL, Ramsey BW, Miller SI. 2006. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 103:19890-19895. https:// doi.org/10.1073/pnas.0606756104.
10. Filkins LM, Graber JA, Olson DG, Dolben EL, Lynd LR, Bhuju S, O’Toole GA. 2015. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa drives S. aureus towards fermentative metabolism and reduced viability in a cystic fibrosis model. J Bacteriol 197:2252-2264. https://doi.org/10.1128/JB.00059-15.
11. Nguyen AT, Jones JW, Ruge MA, Kane MA, Oglesby-Sherrouse AG. 2015. Iron depletion enhances production of antimicrobials by Pseudomonas aeruginosa. J Bacteriol 197:2265-2275. https://doi.org/10.1128/JB.00072-15.
12. Korgaonkar A, Trivedi U, Rumbaugh KP, Whiteley M. 2013. Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection. Proc Natl Acad Sci U S A 110:1059-1064. https://doi.org/10.1073/pnas.1214550110.
13. Haba E, Pinazo A, Jauregui O, Espuny MJ, Infante MR, Manresa A. 2003. Physicochemical characterization and antimicrobial properties of rhamnolipids produced by Pseudomonas aeruginosa 47T2 NCBIM 40044. Biotechnol Bioeng 81:316-322. https://doi.org/10.1002/bit.10474.
14. Bharali P, Saikia JP, Ray A, Konwar BK. 2013. Rhamnolipid (RL) from Pseudomonas aeruginosa OBP1: a novel chemotaxis and antibacterial agent. Colloids Surf B Biointerfaces 103:502-509. https://doi.org/10.1016/j.colsurfb.2012.10.064.
15. Deziel E, Lepine F, Milot S, He J, Mindrinos MN, Tompkins RG, Rahme LG. 2004. Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A 101:1339-1344. https://doi.org/10.1073/pnas.0307694100.
16. Hazan R, Que YA, Maura D, Strobel B, Majcherczyk PA, Hopper LR, Wilbur DJ, Hreha TN, Barquera B, Rahme LG. 2016. Auto poisoning of the respiratory chain by a quorum-sensing-regulated molecule favors biofilm formation and antibiotic tolerance. Curr Biol 26:195-206. https://doi.org/10.1016/j.cub.2015.11.056.
17. Limoli DH, Yang J, Khansaheb MK, Helfman B, Peng L, Stecenko AA, Goldberg JB. 2016. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes. Eur J Clin Microbiol Infect Dis 35:947-953. https://doi.org/10.1007/s10096-016-2621-0.
18. Maliniak ML, Stecenko AA, Mc Carty NA. 2016. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: a single-center study. J Cyst Fibros 15:350-356. https://doi.org/ 10.1016/j.jcf.2015.10.014.
19. Hubert D, Reglier-Poupet H, Sermet-Gaudelus I, Ferroni A, Le Bourgeois M, Burgel PR, Serreau R, Dusser D, Poyart C, Coste J. 2013. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. J Cyst Fibros 12:497-503. https://doi.org/10.1016/j.jcf.2012.12.003.
20. Cystic Fibrosis Foundation. 2016. Cystic Fibrosis Foundation patient registry 2010 annual data report. Cystic Fibrosis Foundation, Bethesda, MD.
21. De Leon S, Clinton A, Fowler H, Everett J, Horswill AR, Rumbaugh KP. 2014. Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect Immun 82:4718-4728. https://doi.org/10.1128/IAI.02198-14.
22. Fazli M, Bjarnsholt T, Kirketerp-Moller K, Jorgensen B, Andersen AS, Krogfelt KA, Givskov M, Tolker-Nielsen T. 2009. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol 47:4084-4089. https://doi.org/10.1128/JCM.01395-09.
23. Hogan DA, Willger SD, Dolben EL, Hampton TH, Stanton BA, Morrison HG, Sogin ML, Czum J, Ashare A. 2016. Analysis of lung microbiota in bronchoalveolar lavage, protected brush and sputum samples from subjects with mild-to-moderate cystic fibrosis lung disease. PLo S One 11:e0149998. https://doi.org/10.1371/journal.pone.0149998.
24. Wakeman CA, Moore JL, Noto MJ, Zhang Y, Singleton MD, Prentice BM, Gilston BA, Doster RS, Gaddy JA, Chazin WJ, Caprioli RM, Skaar EP. 2016. The innate immune protein calprotectin promotes Pseudomonas aeruginosa and Staphylococcus aureus interaction. Nat Commun 7:11951. https://doi.org/10.1038/ncomms11951.
25. Govan JR, Deretic V. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539-574.
26. Bragonzi A, Wiehlmann L, Klockgether J, Cramer N, Worlitzsch D, Doring G, Tummler B. 2006. Sequence diversity of the muc ABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 152:3261-3269. https://doi.org/10.1099/mic.0.29175-0.
27. Tart AH, Wolfgang MC, Wozniak DJ. 2005. The alternative sigma factor Alg T represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of fle Q. J Bacteriol 187:7955-7962. https://doi.org/10.1128/JB.187.23.7955-7962.2005.
28. Firoved AM, Deretic V. 2003. Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. J Bacteriol 185:1071-1081. https://doi.org/10.1128/JB.185.3.1071-1081.2003.
29. Rau MH, Hansen SK, Johansen HK, Thomsen LE, Workman CT, Nielsen KF, Jelsbak L, Hoiby N, Yang L, Molin S. 2010. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol 12:1643-1658. https://doi.org/10.1111/j.1462-2920.2010.02211.x.
30. Wood LF, Ohman DE. 2009. Use of cell wall stress to characterize σ22 (Alg T/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa. Mol Microbiol 72:183-201. https://doi.org/10.1111/ j.1365-2958.2009.06635.x.
31. Ciofu O, Lee B, Johannesson M, Hermansen NO, Meyer P, Hoiby N, Scandinavian Cystic Fibrosis Study Consortium. 2008. Investigation of the alg T operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 154:103-113. https://doi.org/10.1099/mic.0.2007/010421-0.
32. Ciofu O, Tolker-Nielsen T, Jensen PO, Wang H, Hoiby N. 2015. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv Drug Deliv Rev 85:7-23. https:// doi.org/10.1016/j.addr.2014.11.017.
33. Goerke C, Wolz C. 2010. Adaptation of Staphylococcus aureus to the cystic fibrosis lung. Int J Med Microbiol 300:520-525. https://doi.org/10.1016/j.ijmm.2010.08.003.
34. Anderson GG, Moreau-Marquis S, Stanton BA, O’Toole GA. 2008. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect Immun 76:1423-1433. https://doi.org/10.1128/IAI.01373-07.
35. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189:8079-8087. https://doi.org/10.1128/JB.01138-07.
36. Linker A, Jones RS. 1966. A new polysaccharide resembling alginic acid isolated from pseudomonads. J Biol Chem 241:3845-3851.
37. Franklin MJ, Nivens DE, Weadge JT, Howell PL. 2011. Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl. Front Microbiol 2:167. https://doi.org/10.3389/fmicb.2011.00167.
38. Whitney JC, Whitfield GB, Marmont LS, Yip P, Neculai AM, Lobsanov YD, Robinson H, Ohman DE, Howell PL. 2015. Dimeric c-di-GMP is required for post-translational regulation of alginate production in Pseudomonas aeruginosa. J Biol Chem 290:12451-12462. https://doi.org/10.1074/jbc.M115.645051.
39. Hickman JW, Tifrea DF, Harwood CS. 2005. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc Natl Acad Sci U S A 102:14422-14427. https://doi.org/10.1073/pnas.0507170102.
40. Kulkarni MM. 2011. Digital multiplexed gene expression analysis using the Nano String n Counter system. Curr Protoc Mol Biol Chapter 25: Unit25B.10. https://doi.org/10.1002/0471142727.mb25b10s94.
41. Gifford AH, Willger SD, Dolben EL, Moulton LA, Dorman DB, Bean H, Hill JE, Hampton TH, Ashare A, Hogan DA. 2016. Use of a multiplex transcript method for analysis of Pseudomonas aeruginosa gene expression profiles in the cystic fibrosis lung. Infect Immun 84:2995-3006. https://doi.org/ 10.1128/IAI.00437-16.
42. Voggu L, Schlag S, Biswas R, Rosenstein R, Rausch C, Gotz F. 2006. Microevolution of cytochrome bd oxidase in staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J Bacteriol 188:8079-8086. https://doi.org/10.1128/JB.00858-06.
43. Lepine F, Milot S, Deziel E, He J, Rahme LG. 2004. Electrospray/mass spectrometric identification and analysis of 4-hydroxy-2-alkylquinolines (HAQs) produced by Pseudomonas aeruginosa. J Am Soc Mass Spectrom 15:862-869. https://doi.org/10.1016/j.jasms.2004.02.012.
44. D’Argenio DA, Calfee MW, Rainey PB, Pesci EC. 2002. Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants. J Bacteriol 184:6481-6489. https://doi.org/10.1128/JB.184.23.6481-6489.2002.
45. Lepine F, Deziel E, Milot S, Rahme LG. 2003. A stable isotope dilution assay for the quantification of the Pseudomonas quinolone signal in Pseudomonas aeruginosa cultures. Biochim Biophys Acta 1622:36-41. https://doi.org/10.1016/S0304-4165(03)00103-X.
46. Abdel-Mawgoud AM, Lepine F, Deziel E. 2010. Rhamnolipids: diversity of structures, microbial origins and roles. Appl Microbiol Biotechnol 86: 1323-1336. https://doi.org/10.1007/s00253-010-2498-2.
47. Deziel E, Lepine F, Milot S, Villemur R. 2000. Mass spectrometry monitoring of rhamnolipids from a growing culture of Pseudomonas aeruginosa strain 57RP. Biochim Biophys Acta 1485:145-152. https://doi.org/ 10.1016/S1388-1981(00)00039-1.
48. Caiazza NC, Shanks RMQ, O’Toole GA. 2005. Rhamnolipids modulate swarming motility patterns of Pseudomonas aeruginosa. J Bacteriol 187: 7351-7361. https://doi.org/10.1128/JB.187.21.7351-7361.2005.
49. Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, Hentzer M, Andersen JB, Givskov M, Conese M, Doring G. 2005. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J Infect Dis 192:410-419. https:// doi.org/10.1086/431516.
50. Jorth P, Staudinger BJ, Wu X, Hisert KB, Hayden H, Garudathri J, Harding CL, Radey MC, Rezayat A, Bautista G, Berrington WR, Goddard AF, Zheng C, Angermeyer A, Brittnacher MJ, Kitzman J, Shendure J, Fligner CL, Mittler J, Aitken ML, Manoil C, Bruce JE, Yahr TL, Singh PK. 2015. Regional isolation drives bacterial diversification within cystic fibrosis lungs. Cell Host Microbe 18:307-319. https://doi.org/10.1016/j.chom.2015.07.006.
51. De Pas WH, Starwalt-Lee R, Van Sambeek L, Ravindra Kumar S, Gradinaru V, Newman DK. 2016. Exposing the three-dimensional biogeography and metabolic states of pathogens in cystic fibrosis sputum via hydrogel embedding, clearing, and r RNA labeling. m Bio 7:e00796-16. https://doi.org/10.1128/m Bio.00796-16.
52. Korgaonkar AK, Whiteley M. 2011. Pseudomonas aeruginosa enhances production of an antimicrobial in response to N-acetylglucosamine and peptidoglycan. J Bacteriol 193:909-917. https://doi.org/10.1128/JB.01175-10.
53. Yang J, Toyofuku M, Sakai R, Nomura N. 2017. Influence of the alginate production on cell-to-cell communication in Pseudomonas aeruginosa PAO1. Environ Microbiol Rep https://doi.org/10.1111/1758-2229.12521.
54. Hassett DJ. 1996. Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J Bacteriol 178: 7322-7325. https://doi.org/10.1128/jb.178.24.7322-7325.1996.
55. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109:317-325. https://doi.org/10.1172/JCI13870.
56. Schmidt A, Hammerbacher AS, Bastian M, Nieken KJ, Klockgether J, Merighi M, Lapouge K, Poschgan C, Kolle J, Acharya KR, Ulrich M, Tummler B, Unden G, Kaever V, Lory S, Haas D, Schwarz S, Doring G. 2016. Oxygen-dependent regulation of c-di-GMP synthesis by Sad C controls alginate production in Pseudomonas aeruginosa. Environ Microbiol 18:3390-3402. https://doi.org/10.1111/1462-2920.13208.
57. Hatch RA, Schiller NL. 1998. Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother 42:974-977.
58. Learn DB, Brestel EP, Seetharama S. 1987. Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect Immun 55:1813-1818.
59. Hassett DJ, Howell ML, Ochsner UA, Vasil ML, Johnson Z, Dean GE. 1997. An operon containing fum C and sod A encoding fumarase C and manganese superoxide dismutase is controlled by the ferric uptake regulator in Pseudomonas aeruginosa: fur mutants produce elevated alginate levels. J Bacteriol 179:1452-1459. https://doi.org/10.1128/jb.179.5.1452-1459.1997.
60. Calfee MW, Shelton JG, Mc Cubrey JA, Pesci EC. 2005. Solubility and bioactivity of the Pseudomonas quinolone signal are increased by a Pseudomonas aeruginosa-produced surfactant. Infect Immun 73: 878-882. https://doi.org/10.1128/IAI.73.2.878-882.2005.
61. Yang L, Liu Y, Markussen T, Hoiby N, Tolker-Nielsen T, Molin S. 2011. Pattern differentiation in co-culture biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa. FEMS Immunol Med Microbiol 62:339-347. https://doi.org/10.1111/j.1574-695X.2011.00820.x.
62. Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, Whitehouse JL, Nash EF, Dewar J, Clayton A, Knox AJ, Camara M, Fogarty AW. 20 October 2016. Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: a longitudinal study. J Cyst Fibros https:// doi.org/10.1016/j.jcf.2016.10.005.
63. Martin LW, Reid DW, Sharples KJ, Lamont IL. 2011. Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Biometals 24: 1059-1067. https://doi.org/10.1007/s10534-011-9464-z.
64. Knutson CA, Jeanes A. 1968. A new modification of the carbazole analysis: application to heteropolysaccharides. Anal Biochem 24: 470-481. https://doi.org/10.1016/0003-2697(68)90154-1.
65. Cesaretti M, Luppi E, Maccari F, Volpi N. 2003. A 96-well assay for uronic acid carbazole reaction. Carbohydr Polym 54:59-61. https://doi.org/10.1016/S0144-8617(03)00144-9.
66. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, James JJ, Maysuria M, Mitton JD, Oliveri P, Osborn JL, Peng T, Ratcliffe AL, Webster PJ, Davidson EH, Hood L, Dimitrov K. 2008. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26:317-325. https://doi.org/10.1038/nbt1385.
67. Imperi F, Tiburzi F, Visca P. 2009. Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 106:20440-20445. https://doi.org/10.1073/pnas.0908760106.